Novartis AG
Utility Patent Applications
Last updated:
List of all Novartis AG patents 676 in total
| Status | Patent |
|---|---|
Application | Utility: 3-(5-AMINO-1-OXOISOINDOLIN-2-YL)PIPERIDINE-2,6-DIONE DERIVATIVES AND USES THEREOF Filling date: 23 Sep 2025 Issue date: 16 Jan 2020 |
Application | Utility: SURFACTANT SYSTEMS FOR CRYSTALLIZATION OF ORGANIC COMPOUNDS Filling date: 23 Sep 2025 Issue date: 16 Jan 2020 |
Application | Utility: ORGANIC COMPOUNDS Filling date: 23 Sep 2025 Issue date: 9 Jan 2020 |
Application | Utility: Novel Amino Pyrimidine Derivatives Filling date: 23 Sep 2025 Issue date: 9 Jan 2020 |
Application | Utility: CERITINIB FORMULATION Filling date: 23 Sep 2025 Issue date: 9 Jan 2020 |
Application | Utility: N-(pyridin-2-yl)pyridine-sulfonamide Derivatives and their Use in the Treatment of Disease Filling date: 23 Sep 2025 Issue date: 2 Jan 2020 |
Application | Utility: HYDROGEL CONTACT LENSES WITH LUBRICIOUS COATING THEREON Filling date: 23 Sep 2025 Issue date: 2 Jan 2020 |
Application | Utility: PULMONARY HYPERTENSION BIOMARKER Filling date: 23 Sep 2025 Issue date: 2 Jan 2020 |
Application | Utility: COMPOUNDS AND COMPOSITIONS FOR INHIBITING THE ACTIVITY OF SHP2 Filling date: 23 Sep 2025 Issue date: 2 Jan 2020 |
Application | Utility: QUANTITATIVE METHODS AND KITS FOR PROVIDING REPRODUCIBLE IHC4 SCORES Filling date: 23 Sep 2025 Issue date: 26 Dec 2019 |
Application | Utility: SYSTEMS, APPARATUSES, AND METHODS FOR THE OPTIMIZATION OF LASER PHOTOCOAGULATION Filling date: 23 Sep 2025 Issue date: 26 Dec 2019 |
Application | Utility: TREATMENT OF CANCER USING ANTI-CD19 CHIMERIC ANTIGEN RECEPTOR Filling date: 23 Sep 2025 Issue date: 26 Dec 2019 |
Application | Utility: 3'END CAPS FOR RNAi AGENTS FOR USE IN RNA INTERFERENCE Filling date: 23 Sep 2025 Issue date: 26 Dec 2019 |
Application | Utility: CD28 COMPOSITIONS AND METHODS FOR CHIMERIC ANTIGEN RECEPTOR THERAPY Filling date: 23 Sep 2025 Issue date: 26 Dec 2019 |
Application | Utility: A Pharmaceutical Composition Comprising An Oxazine Derivative And Its Use In The Treatment Or Prevention Of Alzheimer's Disease Filling date: 23 Sep 2025 Issue date: 26 Dec 2019 |
Application | Utility: DIP TUBE Filling date: 23 Sep 2025 Issue date: 26 Dec 2019 |
Application | Utility: HUMANIZED IMMUNOBINDERS OF CELL-SURFACE ANTIGENS Filling date: 23 Sep 2025 Issue date: 19 Dec 2019 |
Application | Utility: METHODS FOR MAKING CONJUGATES FROM DISULFIDE-CONTAINING PROTEINS Filling date: 23 Sep 2025 Issue date: 19 Dec 2019 |
Application | Utility: SYSTEM FOR DISINFECTING CONTACT LENSES Filling date: 23 Sep 2025 Issue date: 19 Dec 2019 |
Application | Utility: BCMA CHIMERIC ANTIGEN RECEPTORS AND USES THEREOF Filling date: 23 Sep 2025 Issue date: 19 Dec 2019 |
Application | Utility: CYTOTOXIC PEPTIDES AND CONJUGATES THEREOF Filling date: 23 Sep 2025 Issue date: 19 Dec 2019 |
Application | Utility: CARBOXAMIDE DERIVATIVES Filling date: 23 Sep 2025 Issue date: 19 Dec 2019 |
Application | Utility: OXAZOLIDIN-2-ONE-PYRIMIDINE DERIVATIVES AND THE USE THEREOF AS PHOSPHATIDYLINOSITOL-3-KINASE INHIBITORS Filling date: 23 Sep 2025 Issue date: 19 Dec 2019 |
Application | Utility: ENGINEERED HETERODIMERIC PROTEINS Filling date: 23 Sep 2025 Issue date: 19 Dec 2019 |
Application | Utility: OPTICAL FIBER HAVING PROXIMAL TAPER FOR OPHTHALMIC SURGICAL ILLUMINATION Filling date: 23 Sep 2025 Issue date: 12 Dec 2019 |
Application | Utility: COMPOUNDS CONTAINING S-N-VALERYL-N-{[2'-(1H-TETRAZOLE-5-YL)-BIPHENYL-4-YL]-METHYL}-VALINE AND (2R,4S)-5-BIPHENYL-4-YL-4-(3-CARBOXY-PROPIONYLAMINO)-2-METHYL-PENTANOIC ACID ETHYL ESTER MOIETIES AND CATIONS Filling date: 23 Sep 2025 Issue date: 12 Dec 2019 |
Application | Utility: COMPOUNDS CONTAINING S-N-VALERYL-N-{[2'-(1H-TETRAZOLE-5-YL)-BIPHENYL-4-YL]-METHYL}-VALINE AND (2R,4S)-5-BIPHENYL-4-YL-4-(3-CARBOXY-PROPIONYLAMINO)-2-METHYL-PENTANOIC ACID ETHYL ESTER MOIETIES AND CATIONS Filling date: 23 Sep 2025 Issue date: 12 Dec 2019 |
Application | Utility: TREATMENT OF CANCER USING CHIMERIC T CELL RECEPTOR PROTEINS HAVING MULTIPLE SPECIFICITIES Filling date: 23 Sep 2025 Issue date: 12 Dec 2019 |
Application | Utility: MULTIFOCAL LENS HAVING REDUCED CHROMATIC ABERRATIONS Filling date: 23 Sep 2025 Issue date: 5 Dec 2019 |
Application | Utility: 3-(1-OXOISOINDOLIN-2-YL)PIPERIDINE-2,6-DIONE DERIVATIVES AND USES THEREOF Filling date: 23 Sep 2025 Issue date: 5 Dec 2019 |
Application | Utility: BINDING MOLECULES AGAINST BCMA AND USES THEREOF Filling date: 23 Sep 2025 Issue date: 5 Dec 2019 |
Application | Utility: SYRINGE Filling date: 23 Sep 2025 Issue date: 5 Dec 2019 |
Application | Utility: DOSING SCHEDULE OF A WNT INHIBITOR AND AN ANTI-PD-1 ANTIBODY MOLECULE IN COMBINATION Filling date: 23 Sep 2025 Issue date: 5 Dec 2019 |
Application | Utility: ENZYMATIC REACTION MEDIUM CONTAINING SURFACTANT Filling date: 23 Sep 2025 Issue date: 5 Dec 2019 |
Application | Utility: COMBINATIONS OF THE CDK4/6 INHIBITOR LEE011 AND THE MEK1/2 INHIBITOR TRAMETINIB, OPTIONALLY FURTHER COMPRISING THE PI3K INHIBITOR BYL719 TO TREAT CANCER Filling date: 23 Sep 2025 Issue date: 5 Dec 2019 |
Application | Utility: Lipids and Lipid Compositions for the Delivery of Active Agents Filling date: 23 Sep 2025 Issue date: 28 Nov 2019 |
Application | Utility: MULTIFOCAL OPHTHALMIC LENS HAVING CHROMATIC ABERRATION CORRECTION Filling date: 23 Sep 2025 Issue date: 28 Nov 2019 |
Application | Utility: Paediatric Compositions For Treating Multiple Sclerosis Filling date: 23 Sep 2025 Issue date: 28 Nov 2019 |
Application | Utility: 3-(1-OXOISOINDOLIN-2-YL)PIPERIDINE-2,6-DIONE DERIVATIVES AND USES THEREOF Filling date: 23 Sep 2025 Issue date: 28 Nov 2019 |
Application | Utility: HIGH CONCENTRATION ANTIBODY AND PROTEIN FORMULATIONS Filling date: 23 Sep 2025 Issue date: 28 Nov 2019 |
Application | Utility: 1,4-DISUBSTITUTED PYRIDAZINE ANALOGS THERE OF AND METHODS FOR TREATING SMN-DEFICIENCY-RELATED CONDITIONS Filling date: 23 Sep 2025 Issue date: 28 Nov 2019 |
Application | Utility: 1-(4-AMINO-5-BROMO-6-(1H-PYRAZOL-1-YL)PYRIMIDIN-2-YL)-1H-PYRAZOL-4-OL AND USE THEREOF IN THE TREATMENT OF CANCER Filling date: 23 Sep 2025 Issue date: 28 Nov 2019 |
Application | Utility: NEW PROCESS FOR EARLY SACUBITRIL INTERMEDIATES Filling date: 23 Sep 2025 Issue date: 28 Nov 2019 |
Application | Utility: THERAPEUTIC USES OF A C-RAF INHIBITOR Filling date: 23 Sep 2025 Issue date: 28 Nov 2019 |
Application | Utility: Combination of PI3K inhibitor and c-MET inhibitor Filling date: 23 Sep 2025 Issue date: 21 Nov 2019 |
Application | Utility: COMPOUNDS AND COMPOSITIONS AS TOLL-LIKE RECEPTOR 7 AGONISTS Filling date: 23 Sep 2025 Issue date: 14 Nov 2019 |
Application | Utility: VISUALIZATION SYSTEMS AND METHODS FOR OPTIMIZED OPTICAL COHERENCE TOMOGRAPHY Filling date: 23 Sep 2025 Issue date: 14 Nov 2019 |
Application | Utility: PHARMACEUTICAL COMBINATION COMPRISING AN ALK INHIBITOR AND A SHP2 INHIBITOR Filling date: 23 Sep 2025 Issue date: 14 Nov 2019 |
Application | Utility: MYOSTATIN, ACTIVIN OR ACTIVIN RECEPTOR ANTAGONISTS FOR USE IN TREATING OBESITY AND RELATED CONDITIONS Filling date: 23 Sep 2025 Issue date: 14 Nov 2019 |
Application | Utility: NEW PICOLINIC ACID DERIVATIVES AND THEIR USE AS INTERMEDIATES Filling date: 23 Sep 2025 Issue date: 14 Nov 2019 |
Showing 550 to 600 of 676 patents.